Targeted Funding Opportunities

Competitive cancer-related funding opportunities to support Chao Family Comprehensive Cancer Center (CFCCC) members are available through both intramural and extramural sources. The extramural funding opportunities listed here are updated regularly, so check often.

 

If there are cancer-related opportunities that you would like us to review for posting, please contact CFCCC Administration (cfcccadmin@hs.uci.edu).

Healing Garden - Discover(small)

UCI Anti-Cancer Challenge Pilot Projects

The UCI Anti-Cancer Challenge is an annual ride, run, and walk that raises funds to support cancer-related pilot studies and early phase clinical trials that have been shown to improve quality of life and save lives. All of the funds raised are directed toward promising research led by UCI or CHOC scientists. For more information about the event, a list of previous and current awardees, and the RFP, please visit the link below.

Learn More

The CFCCC curates a list of cancer-relevant federal, non-federal, and limited submission opportunities. Search for extramural funding opportunities using the fields below.

Precision Approaches in Radiation Synthetic Combinations (PAIRS) (R21 Clinical Trial Optional)

PAR-22-199. Multiple application deadlines. LOI due 30 days prior to application due date. Earliest LOI deadline (new): Sept 16, 2022

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits R21 research projects that seek to investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments.

Precision Approaches in Radiation Synthetic Combinations (PAIRS) (R01 Clinical Trial Optional)

PAR-22-198. Multiple application deadlines. LOI due 30 days before application due date. Earliest LOI due date (new): Sept 5, 2022.
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits R01 research projects that seek to investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments.

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)

PAR-22-165. $275K/2 years. Multiple application deadlines. Earliest deadline for new applications: October 5, 2022.
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication pilot interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)

PAR-22-164. $500K/year (5 years). Multiple application deadlines. Earliest deadline for new applications: October 5, 2022.
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Research Projects in Physical Sciences-Oncology (U01-Clinical Trial Optional)

PAR-22-147. $400K/year (5 years). Earliest submission-June 8, 2022.
This Funding Opportunity Announcement (FOA) invites U01 cooperative agreement applications for Physical Science-Oncology Projects (PS-OP). The goal of the Physical Sciences-Oncology Network (PS-ON) is to foster the convergence of physical sciences approaches and perspectives with cancer research to advance our understanding of cancer biology and oncology by forming transdisciplinary teams of physical scientists and cancer biologists/physician scientists. Examples of physical scientists may include engineers, physicists, mathematicians, chemists, and computer scientists. The PS-OPs, individually and as a collaborative Network along with other PS-OPs and the Physical Sciences-Oncology Centers (PS-OC), will support transdisciplinary research that: (1) establishes a physical sciences perspective within the cancer research community; (2) facilitates team science and field convergence at the intersection of physical sciences and cancer research; and (3) collectively tests physical sciences-based experimental and theoretical concepts of cancer and promotes innovative solutions to address outstanding questions in cancer research.